• Endocrinology @Point of Care Podcasts

  • 著者： @Point of Care
  • ポッドキャスト

Endocrinology @Point of Care Podcasts

著者： @Point of Care
無料で聴く

  • サマリー

  • Our @Point of Care Endocrinology Podcasts have healthcare experts discussing and providing information related to endocrinology diagnosis, treatment, management, and other important information.
    Copyright 2021 At Point of Care, LLC. All rights reserved.
    続きを読む 一部表示

あらすじ・解説

Our @Point of Care Endocrinology Podcasts have healthcare experts discussing and providing information related to endocrinology diagnosis, treatment, management, and other important information.
Copyright 2021 At Point of Care, LLC. All rights reserved.
衛生・健康的な生活
続きを読む 一部表示
エピソード
  • S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action

    S1E6 - SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action
    2021/05/07
    Visit http://morningcommutepodcast.com/SGLT2inhibitors6 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, Dr. James Januzzi and Dr. Silvio Inzucchi discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They attribute this to cardiologists moving beyond the so-called glucocentric view and focusing on how diabetes therapies might help reduce cardiovascular risk as well. Drs. Januzzi and Inzucchi will also discuss the recent guidelines that now incorporate sodium-glucose cotransporter 2 (SGLT-2) inhibitors into clinical pathways.
    続きを読む 一部表示
    24 分
  • S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

    S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection
    2021/05/07

    Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
    続きを読む 一部表示
    24 分
  • S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

    S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit
    2021/05/07

    Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.
    続きを読む 一部表示
    25 分

Endocrinology @Point of Care Podcastsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。